My child has
Your opinion means a lot. We'd love to hear your thoughts on how we're doing.
Dr. Heym knew early in medical school that he wanted to work with children who were facing significant challenges. Oncology provides those challenges in ways that are fascinating both medically and scientifically. Pediatrics also provides close bonds with both patients and their families.
"What an honor. Parents come to me with the most important thing in the world: their child," says Dr. Heym. The intimate relationships he forms with families are accompanied with a great sense of gratitude and appreciation. And he adds, "Often I’m a lot more comfortable with young people than I am adults."
Originally from Long Island, Dr. Heym says people are surprised at a New Yorker with a sunny, pleasant, caring disposition. He approaches every case with the words “care and cure.” And he is ever conscious to retain humility and always have a giving heart.
Dr. Heym is also a parent who spends as much time as possible being a father. Once, one of his children asked him "Daddy, if you won the lottery, would you quit your job?" He replied, "Probably." To which his child said, "No Daddy, you can’t, you have too important of a job."
HEYM, K. M., Gressett Ussery, S. M., TRINKMAN, H., & Philpot, L. M. (2015). Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: A predominance of musculoskeletal pain. Journal of Pediatric hematology/oncology, 37(2), e111-3.
Basha, R., Sabnis, N., HEYM, K. M., BOWMAN, W. P., & Lacko, A. G. (2014). Targeted nanoparticles for pediatric leukemia therapy. Frontiers in Oncology, 4, 101.
Berres, M. L., Lim, K. P., Peters, T., Price, J., Takizawa, H., Salmon, H., Idoyaga, J., Ruzo, A., Lupo, P. J., Hicks, M. J., Shih, A., Simko, S. J., Abhyankar, H., Chakraborty, R., Leboeuf, M., Beltrao, M., Lira, S. A., HEYM, K. M., Bigley, V., Collin, M., Manz, M. G., McClain, K., Merad, M., & Allen, C. E. (2014). BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine, 211(4), 669-683.
Thienprayoon, R., HEYM, K. M., Pelfrey, L., & Bowers, D. C. (2013). Accidental overdose of intrathecal cytarabine in children. Annals of Pharmacotherapy, 47(5), e24.
CABALLERO, R., POOL, C., L., WOLF, R. M., HEYM, K. M., & BOWMAN, W. P. (2012). ECMO support fo the oncologic and/or immune-suppressed patient. Paper presented at the 24th Annual ELSO (Extracorporial Life Support Organization) Conference, Philadelphia, PA. April 13-15, 2012
MURRAY, J. C., AKERS, L. J., HEYM, K. M., & Biegel, J. (2012). Sequential childhood neoplasms-leukemia following central nervous system tumors. Paper presented at the Proceedings of the American Society of Pediatric Hematology/Oncology (ASPHO). New Orleans, LA. May 9-12, 2012, 58(7) 1056.
Inaba, H., Rubnitz, J. E., Coustan-Smith, E., Li, L., Furmanski, B. D., Mascara, G. P., HEYM, K. M., Christensen, R., Onciu, M., Shurtleff, S. A., Pounds, S. B., Pui, C. H., Ribeiro, R. C., Campana, D., & Baker, S. D. (2011). Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 29(24), 3293-3300.
Leen, A., Ratnayake, M., Foster, A., HEYM, K. M., Ahmed, N., Rooney, C. M., & Gottschalk, S. (2007). Contact-activated monocytes: Efficient antigen presenting cells for the stimulation of antigen-specific T cells. Journal of Immunotherapy (Hagerstown, Md.: 1997), 30(1), 96-107.
682.885.4000 | Contact Us | Legal | Privacy | Patients
and Parents Rights
Copyright 2016 by Cook Children's Health Care System, Fort Worth, Texas